In CD34-positive AML, CD34+CD38– HSC are, like in CD34-negative AML, ALDHbright while the LSC are ALDHlow and either of the CD34+ or CD34– immunophenotype. This evidence concerns the gene CD34 and acute myeloid leukemia.